NARI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NARI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Inari Medical's quarterly cash and cash equivalents increased from Jun. 2023 ($57.84 Mil) to Sep. 2023 ($89.18 Mil) but then stayed the same from Sep. 2023 ($89.18 Mil) to Dec. 2023 ($38.60 Mil).
Inari Medical's annual cash and cash equivalents declined from Dec. 2021 ($92.75 Mil) to Dec. 2022 ($60.22 Mil) and declined from Dec. 2022 ($60.22 Mil) to Dec. 2023 ($38.60 Mil).
The historical data trend for Inari Medical's Cash And Cash Equivalents can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inari Medical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Cash And Cash Equivalents | Get a 7-Day Free Trial | 23.64 | 114.23 | 92.75 | 60.22 | 38.60 |
Inari Medical Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cash And Cash Equivalents | Get a 7-Day Free Trial | 60.22 | 56.56 | 57.84 | 89.18 | 38.60 |
Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.
Inari Medical (NAS:NARI) Cash And Cash Equivalents Explanation
A high number means either:
1) The company has competitive advantage generating lots of cash
2) Just sold a business or bonds (not necessarily good)
A low stockpile of cash usually means poor to mediocre economics.
There are 3 ways to create large cash reserve.
1) Sell new bonds or equity to public
2) Sell business or asset
3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)
When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.
Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.
Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.
Be Aware
Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.
Thank you for viewing the detailed overview of Inari Medical's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.
William Hoffman | director, officer: President and CEO | C/O INARI MEDICAL, INC., 9 PARKER, SUITE 100, IRVINE CA 92618 |
Mitch C. Hill, | officer: Chief Financial Officer | 1009 TENNYSON DRIVE, SOUTHLAKE TX 76902 |
Andrew Hykes | officer: Chief Operating Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
Thomas Tu | officer: Chief Medical Officer | C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618 |
Donald B Milder | director | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
Robert Keith Warner | director | C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Cynthia L Lucchese | director | 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260 |
Mead Dana G Jr. | director | 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Rebecca Chambers | director | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Jonathan D Root | director | 2735 SAND HILL ROAD, MENLO PARK CA 94025 |
Cooperatieve Gilde Healthcare Iv U.a. | 10 percent owner | NEWTONLANN 51, UTRECHT P7 3508AB |
Kirk G. Nielsen | director, 10 percent owner | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Gilde Healthcare Iv Management B.v. | 10 percent owner | NEWTONLAAN 91, UTRECHT P7 3584 BP |
Gilde Healthcare Holding B.v. | 10 percent owner | NEWTONLAAN 91, PO BOX 85067, 3508 UTRECHT P7 AB |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 05-19-2023
By GuruFocus Research • 11-18-2023
By sperokesalga sperokesalga • 06-07-2023
By Stock market mentor Stock market mentor • 01-12-2023
By sperokesalga sperokesalga • 05-22-2023
By Value_Insider Value_Insider • 11-02-2022
By Marketwired • 08-24-2023
By GuruFocus Research • 11-01-2023
By Value_Insider Value_Insider • 11-03-2022
By GuruFocus Research • 09-14-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.